A new site set up to highlight pharmaceutical companies and institutions guilty of not publishing results from their clinical trials have just published its first list of shame.

And the results are quite confronting, revealing that nearly half of all clinical trials registered on ClinicalTrials.gov over the past 10 years did not publish their results.

The multinational pharmaceutical company Sanofi tops the list, having failed to publish from results two thirds of the trials it conducted over the past decade.

Next comes Novartis Pharmaceuticals (201, 37.6%), followed by the US National Cancer Institute (194, 34.8%), Assistance Publique-Hôpitaux de Paris (186, 63.7%), and GlaxoSmithKline (183, 22.6%).

TrialsTracker, developed by academics at Oxford University in the UK, can be accessed here.